• Home
  • About Us
    • Company Profile
    • Development Process
    • Quality Control
    • Sustainable Development
  • Products
    • RNA monomers & Derivatives
    • DNA monomers & Derivatives
    • Polynucleotide Series
    • Cyclic Nucleotide Series
    • Sugar nucleotide series
    • Other Series
  • Services
    • Custom Services
    • Product Brochure
  • News
    • Company News
    • Industry Trends
  • Contact Us
  • EN
  • CN
  • 끠 Search
    Product ꀁ
    • Product
    • Article

News Dynamics

Provides you with the latest company and industry information

Stay up to date with the latest company news and upcoming events

  • Repurposing Toxins as Signals: How the Kongming System Achieves Ultrasensitive Immunity Through Filament-Mediated Allostery

    넶0 2026-02-04
  • Decoding the Tumor's Invisible Shield: CARM1-ALIX Axis Drives Hypoxanthine-Enriched Exosomes to Subvert CD8+ T Cell Immunity

    넶0 2026-01-28
  • AHCY-Adenosine Complex: A Novel Prognostic Biomarker and Precision Therapeutic Target in Cancer

    넶2 2026-01-22
  • From Bench to Bedside: Targeted mRNA Delivery Achieved with Sustainable, Lyophilizable Nanoparticles

    넶1 2026-01-16
  • Professional Perspective: "mRNA Technology Breaks the 40-Year Deadlock in HIV Vaccine Development"

    넶0 2026-01-13
  • More Potent, Less Toxic: How a Novel MeDZ Lipid is Revolutionizing mRNA Cancer Vaccines

    넶1 2026-01-05
  • A New Dawn for Hepatitis B Treatment: Can mRNA and Gene Editing Deliver a Cure?

    넶3 2025-12-31
  • Breaking the Cycle of Non-Healing Diabetic Ulcers: Multifunctional Aerogel Dressing Offers a Comprehensive Therapeutic Strategy

    넶6 2025-12-25
  • About Meiya
  • Company Profile
  • Development process
  • Quality Control
  • sustainable development
  • Product Center
  • RNA monomers & Derivatives

  • DNA monomers & Derivatives

  • Polynucleotide Series

  • Cyclic Nucleotide Series

  • Sugar nucleotide series

  • Other Series

  • Custom Solutions

  • Service Support
  • Custom Services
  • Product Brochure
  • Related Links
  • Website
  • News Dynamics
  • Contact Us

Address

Headquarters: Hangzhou Meiya Pharmaceutic

al Co., Ltd.

Room 101, Building 12, Yinhai Science and Tech

nology Innovation Center, 501 Fucheng Road,

Xiasha Street, Qiantang District, Hangzhou City,

Zhejiang Province

 

Sales Company: Shanghai Nucleotide Biotec

hnology Co., Ltd.

 

 

Production base: Meiya Pharmaceutical Hai

an Co., Ltd.

 

Copyright©2025 Hangzhou Meiya Pharmaceutical Co., Ltd.
 本网站由阿里云提供云计算及安全服务
本网站支持 IPv6
 本网站由阿里云提供云计算及安全服务
本网站支持 IPv6
 本网站由阿里云提供云计算及安全服务
本网站支持 IPv6
 本网站由阿里云提供云计算及安全服务
本网站支持 IPv6